The authors analyzed data on patients with relapsing-remitting MS who were beginning DMTs or clinical monitoring at 68 neurology centers in 21 ... read more
Earlier Treatment With Disease-Modifying Therapies Decreases Risk of MS Progression
Earlier Treatment With Disease-Modifying Therapies Decreases Risk of MS Progression
